SAVE OUR SOCIETY FROM DRUGS INC (EIN 593470019) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1997

Legal Domicile

Principal Officer

JAMES W HOLTON ESQ

Phone

7278280211

Tax Period

2023-10-01 to 2024-09-30

SAVE OUR SOCIETY FROM DRUGS INC, founded in 1997, is a community nonprofit that reported $1.2M in total revenue in fiscal year 2023. Revenue surged 1860% from the prior year, signaling strong growth momentum. Expenses of $1.1M left a modest 5% surplus.

Mission

SAVE OUR SOCIETY FROM DRUGS IS A 501(C)(4) ORGANIZATION FORMED TO EDUCATE THE PUBLIC AND LAW-MAKERS ABOUT THE IMPACT OF DRUG POLICY, AND TO SUPPORT EFFECTIVE DRUG POLICY AND PUSH BACK AGAINST PENDING DRUG-RELATED LEGISLATION AND BALLOT INITIATIVES THAT ARE INEFFECTIVE OR DAMAGING THROUGH GRASSROOTS AND DIRECT LOBBYING.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $1,188,659

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $1,188,659

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $471

Program Expenses $1,112,848

Other Expenses $1,131,296

TOTAL EXPENSES $1,131,296

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,188,659	$60,650	+18.6%
Expenses	$1,131,296	$145,445	+6.8%
Net Income	$57,363	$-84,795	-1.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JAMES W HOLTON ESQ	CHAIR/DIRECT	0.10	Officer Director	$0	$0	$0
T WILLARD FAIR	VICE CHAIR/D	0.10	Officer Director	$0	$0	$0
JAMES C FRISCHE	DIRECTOR	0.10	Director	$0	$0	$0
STEPHANIE HAYNES	SEC/TREAS/DI	0.10	Officer Director	$0	$0	$0
CALVINA FAY OLIVERI	DIRECTOR	0.10	Director	$0	$0	$0
AMY RONSHAUSEN	EXECUTIVE DI	5.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$1,188,659	$1,131,296	$96,091	$57,363
2023	$60,650	$145,445	$43,125	$-84,795
2022	$365,200	$247,578	$127,920	$117,622
2021	$78,229	$75,176	$10,298	$3,053
2020	$74,465	$83,380	$7,245	$-8,915
2019	$105,063	$127,787	$16,160	$-22,724
2018	$84,881	$128,360	$38,884	$-43,479

SAVE OUR SOCIETY FROM DRUGS INC